Global /Australia /Healthcare /Medical Devices /OSL

OncoSil Medical Ltd.

OSL

• ASX: OSL • Delayed

0.4900AUD 0%

0.3497 USD

As of 5 June 2026, OncoSil Medical Ltd. has a market cap of $10.73M USD, ranking #40932 globally and #1313 in Australia. It ranks #3637 in the Healthcare sector, and #768 in the Medical Devices industry.

Global Rank

40932

Country Rank

1313

Sector Rank

3637

Industry Rank

768

Key Stats

Market Cap

$10.73MUSD

15.04M AUD

Enterprise Value

$8.73MUSD

12.23M AUD

Revenue (TTM)

$2.66MUSD

3.72M AUD

EBITDA (TTM)

-$9.26MUSD

-12.98M AUD

Net Income (TTM)

-$9.22MUSD

-12.92M AUD

PS Ratio

4.0

PB Ratio

3.9

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Nigel Lange open_in_new

Founded

2005

Website

oncosil.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-3.9%	-4.9%	-41%	-67%	-49%	-76%	-90%	-99%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	OSL OncoSil Medical Ltd ISIN: AU000000OSL3 Shares Out.: Shares Outstanding: 30.889M¹ Shares Float: 29.176M² TV: TradingView: ASX: OSL SA: Stock Analysis: ASX: OSL YF: Yahoo Finance: OSL.AX GF: Google Finance: ASX: OSL BA: Barron's: OSL MS: Morningstar: XASX: OSL	0.4900 AUD	TV: TradingView: ASX: OSL SA: Stock Analysis: ASX: OSL YF: Yahoo Finance: OSL.AX GF: Google Finance: ASX: OSL BA: Barron's: OSL MS: Morningstar: XASX: OSL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About OncoSil Medical Ltd.

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 39K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 24K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 7K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 7K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 1K%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 1K%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 1M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 1M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 1M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 1M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 949K%	22.2	Ireland

chevron_leftBack